Autobio Diagnostics Co., Ltd.

SHSE:603658 Stock Report

Market Cap: CN¥25.7b

Autobio Diagnostics Past Earnings Performance

Past criteria checks 4/6

Autobio Diagnostics has been growing earnings at an average annual rate of 13.3%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 12.6% per year. Autobio Diagnostics's return on equity is 15.1%, and it has net margins of 27.8%.

Key information

13.3%

Earnings growth rate

12.2%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate12.6%
Return on equity15.1%
Net Margin27.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

Dec 20
Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

Autobio Diagnostics Co., Ltd.'s (SHSE:603658) Prospects Need A Boost To Lift Shares

Nov 24
Autobio Diagnostics Co., Ltd.'s (SHSE:603658) Prospects Need A Boost To Lift Shares

Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate

Aug 09
Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate

Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet

Jul 18
Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet

Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

May 21
Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings

Feb 27
Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings

Revenue & Expenses Breakdown

How Autobio Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:603658 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,5811,273979706
30 Jun 244,5431,291953678
31 Mar 244,4961,300949655
31 Dec 234,4441,217941656
30 Sep 234,4031,169925633
30 Jun 234,4791,180915627
31 Mar 234,4471,169864600
31 Dec 224,4421,167874568
30 Sep 224,3521,156879540
30 Jun 224,1591,095827508
31 Mar 223,9801,042810498
31 Dec 213,766974772481
30 Sep 213,626950733445
30 Jun 213,450887713420
31 Mar 213,245826665376
31 Dec 202,978748616343
30 Sep 202,833751587322
30 Jun 202,706728574321
31 Mar 202,682746560318
31 Dec 192,679774564312
30 Sep 192,463689524294
30 Jun 192,261636467261
31 Mar 192,062588445229
31 Dec 181,930563404213
30 Sep 181,777534383188
30 Jun 181,666502292234
31 Mar 181,574475307191
31 Dec 171,400447301143
30 Sep 171,27141929399
30 Jun 171,1293933550
31 Mar 171,0303633240
31 Dec 169803503010
30 Sep 168983352600
30 Jun 168373172250
31 Mar 167522782200
31 Dec 157162782030
31 Dec 145632081730
31 Dec 134091241500

Quality Earnings: 603658 has high quality earnings.

Growing Profit Margin: 603658's current net profit margins (27.8%) are higher than last year (26.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 603658's earnings have grown by 13.3% per year over the past 5 years.

Accelerating Growth: 603658's earnings growth over the past year (8.8%) is below its 5-year average (13.3% per year).

Earnings vs Industry: 603658 earnings growth over the past year (8.8%) exceeded the Medical Equipment industry -8.8%.


Return on Equity

High ROE: 603658's Return on Equity (15.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:36
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Autobio Diagnostics Co., Ltd. is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sandra SunBofA Global Research
Pei ChengChina Galaxy Securities Co., Ltd.
Jin ZhangChina International Capital Corporation Limited